Acorda Therapeutics, Inc.: 10-K filed 2011-03-01
What Acorda Therapeutics, Inc. reported in its annual report filed 2011-03-01 (fiscal FY 2010): 28 published measures, 75 facts as tagged in accession 0001008848-11-000018.
This filing
- Form
- 10-K (annual report)
- Filed
- 2011-03-01
- Fiscal period
- fiscal FY 2010
- Accession
- 0001008848-11-000018 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Acorda Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 342,101,444 | USD | |
| At 2009-12-31 | 319,470,618 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 151,260,592 | USD | |
| At 2009-12-31 | 137,332,768 | USD | |
| At 2008-12-31 | 207,157,345 | USD | |
| At 2007-12-31 | 63,432,648 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 34,640,716 | USD | |
| At 2009-12-31 | 47,314,412 | USD | |
| At 2008-12-31 | 29,612,916 | USD | |
| At 2007-12-31 | 16,810,415 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | -11,769,445 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -83,940,471 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -74,340,640 | USD | 366 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | -19,216,004 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 38,634,337 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -49,155,272 | USD | 366 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 2,446,185 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 1,147,502 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 1,248,678 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 1,191,340 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -4,527,785 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 203,248,370 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 5,350,968 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -16,405,056 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -141,290,597 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | -440,086,326 | USD | |
| At 2009-12-31 | -428,316,881 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 3,202,736 | USD | |
| At 2009-12-31 | 1,891,321 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 17,777,242 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 12,277,929 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 9,804,986 | USD | 366 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | -8,429,863 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -81,257,242 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -73,439,354 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 311,168,647 | USD | |
| At 2009-12-31 | 293,280,347 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 3,922,686 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 4,414,812 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 5,591,426 | USD | 366 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 94,249,568 | USD | |
| At 2009-12-31 | 72,900,319 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 16,961,250 | USD | |
| At 2009-12-31 | 11,613,434 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 22,271,697 | USD | |
| At 2009-12-31 | 5,739,013 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 199,435,103 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 135,930,877 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 121,266,151 | USD | 366 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 133,316,518 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 90,260,678 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 73,306,761 | USD | 366 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 30,600,369 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 34,611,278 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 36,604,478 | USD | 366 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | -12,579 | USD | |
| At 2009-12-31 | 108,613 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 21,336,259 | USD | |
| At 2009-12-31 | 17,148,631 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 343,801 | USD | |
| At 2009-12-31 | 440,318 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-12-31 | 34,121,869 | USD | |
| At 2009-12-31 | 14,975,794 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | -11,890,637 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -84,644,616 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -73,823,675 | USD | 366 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 3,950,591 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 2,761,508 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 3,480,768 | USD | 366 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | -3,339,582 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -2,683,229 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -901,286 | USD | 366 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | -16,532,684 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -1,116,527 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -356,905 | USD | 366 |
Inspect the source
- Entity
- Acorda Therapeutics, Inc. / CIK 0001008848
- Captured
- SEC response SHA-256
c2d58bfc837ef6a6ec03ace43e8d0507ad0968fa8666de37eb863e1308c9b0d4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001008848.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))